Samsung Electronics to invest KRW 666.2 billion in Samsung Biologics rights offering

Samsung Electronics announced plans to invest KRW 666.2 billion in a rights offering conducted by Samsung Biologics, representing a significant capital allocation toward the biotechnology affiliate.

Detected & updated continuously · Source: Nebula